0001203311-23-000065.txt : 20230609 0001203311-23-000065.hdr.sgml : 20230609 20230609185002 ACCESSION NUMBER: 0001203311-23-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIMES VAUGHN B CENTRAL INDEX KEY: 0001361966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 231006734 MAIL ADDRESS: STREET 1: C/O SEATTLE GENETICS, INC. STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0407 4 2023-06-07 0 0001060736 Seagen Inc. SGEN 0001361966 HIMES VAUGHN B 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Technical Officer 1 Common Stock 2023-06-07 4 M 0 16215 41.04 A 60052 D Common Stock 2023-06-07 4 S 0 16215 195.2865 D 43837 D Common Stock 119471 I by Trust Non-Qualified Stock Option (right to buy) 41.04 2023-06-07 4 M 0 16215 0.0 D 2023-08-19 Common Stock 16215 0 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a written plan, entered into on November 29, 2022, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Reflects sales of common stock executed in multiple transactions at prices ranging from $195.00 to $195.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Options vested at a rate of 25% on 8/19/14 and monthly thereafter until all the options were fully vested on 8/19/17. By: /s/ Jennifer Prosba For: Vaughn B Himes 2023-06-09